I already received my parcel, I had a problem as the courier wanted to deliver
to my home as they claim they cannot place the order into my postbox. This was
my preferred option.
There is not someone at home always, so we had to get the parcel to my office.
No problem with that.
I did have an enquiry into the 4 extra pills, and this was delivered within a
few days via airmail to my post box.
I would suggest you attend to this part of your process as the extra cost is
unnecessary. Include everything into one parcel.
All in all, good service.
- Jan
HCV Patients May Be Able to Delay Therapy - MedPage Today
HCV Patients May Be Able to Delay TherapyMedPage TodayThe addition of new protease inhibitors telaprevir (Incivek) and boceprevir (Victrelis) to previous standard therapy of interferon and ribavirin have significantly boosted sustained viral response for many patients, especially for blacks and Latinos, .
Medivir: Interim Report, 1 January -- 31 March 2012 - MarketWatch (press release)
Medivir: Interim Report, 1 January -- 31 March 2012MarketWatch (press release)Apart from interferon and ribavirin-free combination trials on TMC435 in phase II, this collaboration now also covers a phase III program Medivir opened 2012 with continued stable sales of Rx pharmaceuticals.
Twelve Weeks of GS-7977 Eliminates HCV as Well as 24 Weeks - Medscape
Twelve Weeks of GS-7977 Eliminates HCV as Well as 24 WeeksMedscapeMay 2, 2012 (Barcelona, Spain) — Twelve weeks of GS-7977 (Gilead Sciences) plus pegylated interferon (pegIFN) and ribavirin was as effective as 24 weeks of treatment in eliminating hepatitis C virus (HCV) genotype 1.
New research reveals effective treatments for gastrointestinal conditions - News-Medical.net
New research reveals effective treatments for gastrointestinal conditionsNews-Medical.
Experts Discuss DAAs for Difficult-To-Treat Hep C Patients - Infectious Disease Special Edition
Infectious Disease Special EditionExperts Discuss DAAs for Difficult-To-Treat Hep C PatientsInfectious Disease Special EditionOverall, the new reports revealed the following: Cirrhotic patients who previously received the standard two-drug therapy and then received telaprevir in combination with pegylated interferon (Peg-IFN) and ribavirin had improved SVR compared with .